alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
#### § 901.33 Initiation of proceeding.

Whenever the Executive Director has reason to believe that an enrolled actuary has violated any provision of the laws or regulations governing enrollment, such individual may be reprimanded or a proceeding may be initiated for the suspension or termination of such individual's enrollment. A reprimand as used in this paragraph is a statement informing the enrolled actuary that, in the opinion of the Executive Director, his/her conduct is in violation of the regulations and admonishing the enrolled actuary that repetition of the conduct occasioning the reprimand may result in the institution of a proceeding for the suspension or termination of the actuary's enrollment. A proceeding for suspension or termination of enrollment shall be initiated by a complaint naming the respondent actuary, signed by the Executive Director and filed in the Executive Director's office. Except in cases where the nature of the proceeding or the public interest does not permit, a proceeding will not be initiated under this section until the facts which may warrant such a proceeding have been called to the attention of the actuary in writing and he/she has been given an opportunity to respond to the allegations of misconduct.
Exhibit
31.1




CERTIFICATION





I, B.K.
Gogia, Chief Executive Officer of the registrant, certify that:





1.           
I have reviewed this Annual Report on Form 10-K of InferX
Corporation;





2.          
 Based on my knowledge, this report does not contain any untrue statement
of a material fact or omit to state a material fact necessary to make the
statements made, in light of the circumstances under which such statements were
made, not misleading with respect to the period covered by this
report;





3.           
Based on my knowledge, the financial statements, and other financial information
included in this annual report, fairly present in all material respects the
financial condition, results of operations and cash flows of the registrant as
of, and for, the periods presented in this report;





4.           
The registrant’s other certifying officer(s) and I are responsible for
establishing and maintaining disclosure controls and procedures (as defined in
Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and
have:





(a)           Designed
such disclosure controls and procedures, or caused such disclosure controls and
procedures to be designed under our supervision, to ensure that material
information relating to the registrant, including its consolidated subsidiaries,
is made known to us by others within those entities, particularly during the
period in which this report is being prepared;





(b)           [this
paragraph has been omitted]





(c)           Evaluated
the effectiveness of the registrant’s disclosure controls and procedures and
presented in this report our conclusions about the effectiveness of the
disclosure controls and procedures, as of the end of the period covered by this
report based on such evaluation; and





(d)           Disclosed
in this report any change in the registrant’s internal control over financial
reporting that occurred during the registrant’s most recent fiscal quarter (the
registrant’s fourth fiscal quarter in the case of an annual report) that has
materially affected, or is reasonably likely to materially affect, the
registrant’s internal control over financial reporting; and





5.            
The registrant’s other certifying officer(s) and I have disclosed, based on our
most recent evaluation of internal control over financial reporting, to the
registrant’s auditors and the audit committee of the registrant’s board of
directors (or persons performing the equivalent functions):





(a)           All
significant deficiencies and material weaknesses in the design or operation of
internal control over financial reporting which are reasonably likely to
adversely affect the registrant’s ability to record, process, summarize and
report financial information; and





(b)           Any
fraud, whether or not material, that involves management or other employees who
have a significant role in the registrant’s internal control over financial
reporting.





Date:  April
15, 2009


By:
            /s/ B.K. GogiaB.K.
      GogiaChief
      Executive Officer
Exhibit
      32.1


**CERTIFICATION**




**Pursuant
      to Section 906 of the Sarbanes-Oxley Act of 2002**


**(Subsections
      (a) and (b) of Section 1350, Chapter 63 of Title 18, United States
      Code)**




Pursuant
      to section 906 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of
      section 1350, chapter 63 of title 18, United States Code), each of the
      undersigned officers of Platinum Energy Resources, Inc., a Delaware corporation
      (the “Company”), does hereby certify, to such officer’s knowledge,
      that:




The
      Annual Report on Form 10-K for the year ended December 31, 2006 (the “Form
      10-K”) of the Company fully complies with the requirements of section 13(a) or
      15(d) of the Securities Exchange Act of 1934, and information contained in
      the
      Form 10-K fairly presents, in all material respects, the financial condition
      and
      results of operations of the Company.




Date: March
                30, 2007
            
            /s/ Mark
                NordlichtMark
                NordlichtChairman
                of the Board






A
      signed
      original of this written statement required by Section 906 has been provided
      to
      the Company and will be retained by the Company and furnished to the Securities
      and Exchange Commission or its staff upon request.
Regulatory Evaluation

Docket No. FAA-2015-5811 Directorate Identifier: 2014-NM-158-AD

If you make changes to the values in the table below, you must ensure the totals update accordingly. If 

they do not, click (or Tab) into and then out of the changed cell.

Estimated Costs:

Action

(e.g., Inspection, 

replacement)

Do not include oncondition costs here

Costs per Product (e.g., aircraft, engine, 

propeller, appliance)

Work-hours

(include 

access, testing, 

and close-up)

Labor 

cost 

(@$85/h

our)

Parts Cost Total Costs 

(labor + 

parts)

Number of 

U.S. 

Registered 

Products

Total Cost 

for U.S. Fleet

Inspection 76.0 $6,460.0

0

$0 $6,460.00 84 $542,640.00

$ 0.00 $ 0.00 $ 0.00

$ 0.00 $ 0.00 $ 0.00

$ 0.00 $ 0.00 $ 0.00

$ 0.00 $ 0.00 $ 0.00

$ 0.00 $ 0.00 $ 0.00

$ 0.00 $ 0.00 $ 0.00

$ 0.00 $ 0.00 $ 0.00

$ 0.00 $ 0.00 $ 0.00

$ 0.00 $ 0.00 $ 0.00

$ 0.00 $ 0.00 $ 0.00

$ 0.00 $ 0.00 $ 0.00

$ 0.00 $ 0.00 $ 0.00

$ 0.00 $ 0.00 $ 0.00

$ 0.00 $ 0.00 $ 0.00

$ 0.00 $ 0.00 $ 0.00

$ 0.00 $ 0.00 $ 0.00

$ 0.00 $ 0.00 $ 0.00

$ 0.00 $ 0.00 $ 0.00

$ 0.00 $ 0.00 $ 0.00

The known number of products in compliance: 0

Total Costs of compliance for U.S. fleet: $542,640

Costs covered under warranty (if known) $0

On-Condition Costs:

Action

(e.g., Inspection, 

replacement)

Work-hours 

(include access, 

testing, and closeup)

Labor cost 

(@$85/hour)

Parts Cost Cost per Product

Modification of 

rear spar

60.0 $5,100.00 $13,664 $18,764.00

Modification of 

pintle and retraction 

jack fitting

600.0 $51,000.00 $0 $51,000.00

New Modification 

requirement 980.0 $83,300.00 $32,727 $116,027.00

$ 0.00 $ 0.00
Special considerations for Economic Analysis (Use this field to explain anything in the Estimated Costs table 

that was assumed or might not be obvious. This field can also be used to explain warranty costs):

Executive Order 12866:

Could the AD be considered a “significant regulatory action”?

YES* NO 

*Explanation: 

DOT Regulatory Policies and Procedures:

Is the AD significant? 

YES* NO 

*Explanation: 

Regulatory Flexibility Act:

Will the AD have a significant economic impact on a substantial number of small entities? Explain for 

either a Yes or No answer.

YES NO 

Explanation: 

Intrastate Aviation in Alaska:

This AD could affect intrastate aviation in Alaska. Is it appropriate to include specific requirements for 

aircraft operated in Alaska where aviation might be the only mode of transportation?

YES* NO 

*Explanation:
NASA LogoNTRSNTRS - NASA Technical Reports ServerSearchmore_vertCollectionsAboutNewsHelpLogin Back to ResultsWave Augmented Diffusers for Centrifugal CompressorsA conceptual device is introduced which would utilize unsteady wave motion to slow and turn flows in the diffuser section of a centrifugal compressor. The envisioned device would substantially reduce the size of conventional centrifugal diffusers by eliminating the relatively large ninety degree bend needed to turn the flow from the radial/tangential to the axial direction. The bend would be replaced by a wall and the flow would instead exit through a series of rotating ports located on a disk, adjacent to the diffuser hub, and fixed to the impeller shaft. The ports would generate both expansion and compression waves which would rapidly transition from the hub/shroud (axial) direction to the radial/tangential direction. The waves would in turn induce radial/tangential and axial flow. This paper presents a detailed description of the device. Simplified cycle analysis and performance results are presented which were obtained using a time accurate, quasi-one-dimensional CFD code with models for turning, port flow conditions, and losses due to wall shear stress. The results indicate that a periodic wave system can be established which yields diffuser performance comparable to a conventional diffuser. Discussion concerning feasibility, accuracy, and integration follow.Document ID19980211303Acquisition SourceLegacy CDMSDocument TypeReprint (Version printed in journal)AuthorsPaxson, Daniel E.*(NASA Lewis Research Center Cleveland, OH United States)*Skoch, Gary J.*(Army Research Lab. Cleveland, OH United States)*Date AcquiredSeptember 6, 2013Publication DateJuly 1, 1998Subject CategoryAircraft Propulsion And PowerReport/Patent NumberNAS 1.15:208480AIAA Paper 98-3401NASA/TM-1998-208480E-11253Meeting InformationMeeting: PropulsionLocation: Cleveland, OHCountry: United StatesStart Date: July 12, 1998End Date: July 15, 1998Sponsors:American Inst. of Aeronautics and Astronautics,American Society of Mechanical Engineers,American Society for Electrical Engineers,Society of Automotive Engineers, Inc.Funding Number(s)PROJECT: RTOP 523-26-33Distribution LimitsPublicCopyrightWork of the US Gov. Public Use Permitted.Available DownloadsNameType19980211303.pdfSTIcloud_downloadcontent_copyvisibilityRelated RecordsThere are no records associated with this record.visibility_offNo Preview Available
 No Fear Act | Freedom of Information Act | Office of the Inspector General | Agency Financial ReportsNASA Web Privacy Policy and Important Notices | NASA Guidelines for Quality of InformationDisclaimers, Copyright, Terms of Use | Accessibility | NASA OCIO | USA.gov | NASA.govContact Us | Site MapSTI LogoNASA Official: JoAnne R. Calhoun Site Curator: STI Compliance and Distribution Services Last Modified: September 12, 2024
I 

114TH CONGRESS 

2D SESSION H. R. 4672 

To amend the Internal Revenue Code of 1986 to make permanent the exception for marginal production from the taxable income limit on percentage 

depletion for oil and natural gas wells. 

IN THE HOUSE OF REPRESENTATIVES 

MARCH 2, 2016 

Ms. JENKINS of Kansas introduced the following bill; which was referred to 

the Committee on Ways and Means 

A BILL 

To amend the Internal Revenue Code of 1986 to make 

permanent the exception for marginal production from 

the taxable income limit on percentage depletion for oil 

and natural gas wells. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 


rfrederick on DSK6VPTVN1PROD with BILLS
2 

•HR 4672 IH

1 SECTION 1. EXCEPTION FOR MARGINAL PRODUCTION 

2 FROM TAXABLE INCOME LIMIT ON PERCENT3 AGE DEPLETION FOR OIL AND NATURAL GAS 

4 WELLS MADE PERMANENT. 

5 (a) IN GENERAL.—Section 613A(c)(6)(H) of the In6 ternal Revenue Code of 1986 is amended to read as fol7 lows: 

8 ‘‘(H) TAXABLE INCOME LIMIT NOT APPLI9 CABLE TO MARGINAL PRODUCTION.—The sec10 ond sentence of subsection (a) of section 613 

11 shall not apply to so much of the allowance for 

12 depletion as is determined under subparagraph 

13 (A).’’. 

14 (b) EFFECTIVE DATE.—The amendment made by 

15 this section shall apply to taxable years ending after the 

16 date of the enactment of this Act. 

Æ 


rfrederick on DSK6VPTVN1PROD with BILLS
1

2

3

4

5

6

7

8

9

10

11

12

13

14

15

16

17

18

19

20

21

22

23

24

25

26

27

28

29

30

DAY ELEV

 827.85

 827.81

 827.76

 827.71

 827.67

 827.65

 827.62

 827.60

 827.61

 827.60

 827.57

 827.58

 827.57

 827.56

 827.55

 827.55

 827.53

 827.52

 827.50

 827.58

 827.63

 827.65

 827.66

 827.72

 827.87

 827.95

 828.00

 828.03

 828.06

 828.06

 34.89

 34.84

 34.79

 34.74

 34.70

 34.67

 34.64

 34.62

 34.63

 34.62

 34.59

 34.60

 34.59

 34.58

 34.57

 34.57

 34.55

 34.54

 34.52

 34.60

 34.65

 34.67

 34.69

 34.75

 34.91

 34.99

 35.04

 35.08

 35.11

 35.11

STORAGE

-0.09

-0.04

-0.05

-0.05

-0.04

-0.02

-0.03

-0.02

+0.01

-0.01

-0.03

+0.01

-0.01

-0.01

-0.01

+0.00

-0.02

-0.01

-0.02

+0.08

+0.05

+0.02

+0.01

+0.06

+0.16

+0.08

+0.05

+0.03

+0.03

+0.00

CHANGE

-6

20

13

10

16

25

20

25

38

26

16

37

26

26

27

32

20

27

21

74

58

42

37

63

111

73

58

45

46

30

INFLOW

 15

 15

 15

 15

 15

 15

 15

 15

 15

 15

 15

 15

 15

 15

 15

 15

 15

 15

 15

 15

 15

 15

 15

 15

 15

 15

 15

 15

 15

 15

SPILL

 19

 20

 20

 20

 20

 20

 20

 20

 16

 16

 16

 16

 15

 15

 15

 15

 15

 15

 15

 15

 15

 15

 15

 15

 15

 15

 15

 14

 14

 14

OUTLET

 3

 6

 5

 2

 2

 1

 1

 1

 1

 1

 1

 1

 1

 2

 2

 2

 1

 2

 2

 2

 1

 1

 1

 1

 1

 1

 1

 0

 1

 1

C.F.S.

 .09

 .18

 .16

 .07

 .05

 .04

 .04

 .04

 .03

 .04

 .04

 .03

 .03

 .05

 .05

 .05

 .03

 .06

 .07

 .06

 .04

 .03

 .03

 .02

 .04

 .02

 .02

 .00

 .03

 .02

INCHES

 .00

 .00

 .00

 .00

 .00

 .18

 .00

 .00

 .00

 .00

 .00

 .09

 .00

 .00

 .00

 .00

 .00

 .00

 .00

 1.13

 .04

 .01

 .00

 .52

 .01

 .00

 .00

 .00

 .00

 .00

PRECIP

UNITED STATES DEPARTMENT OF THE INTERIOR

U.S. BUREAU OF RECLAMATION-ORLAND PROJECT-CALIFORNIA

NOVEMBER 2011 RUN DATE: 02/07/2012

IN LAKE

EVAPORATION

INCHES

C.F.S.

COMPUTED*

1000 ACRE-FEET

RELEASE - C.F.S.

TOTALS +.13 1,056 490 450 48 1.46 1.98

ACRE-FEET +130 2,095 972 893 95

COMMENTS:

* COMPUTED INFLOW IS THE SUM OF CHANGE IN STORAGE, RELEASES AND EVAPORATION.

DATA BASED ON 24 HOUR PERIOD ENDING 0800 HOURS.

SUMMARY

RELEASE (ACRE-FEET)

SPILL 893

OUTLET

TOTAL

 972

 1,865

PRECIPITATION

THIS MONTH =

TO DATE =

 1.98

JULY 1, 2011 3.33

 34.97

STONY GORGE RESERVOIR DAILY OPERATIONS
#### The People of the State of Illinois, Plaintiff-Appellee, *v.*Curtis Evans, Defendant-Appellant.

(No. 57452;

First District (2nd Division) —

July 24, 1973.

James J. Doherty, Public Defender, of Chicago, for appellant.

Bernard Carey, State’s Attorney, of Chicago, for the People.

PER CURIAM.

LEIGHTON, J., took no part.
[Federal Register Volume 69, Number 184 (Thursday, September 23, 2004)]
[Notices]
[Pages 57099-57100]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 04-21327]


=======================================================================
-----------------------------------------------------------------------

OFFICE OF NATIONAL DRUG CONTROL POLICY


Meeting of the Drug Control Research, Data, and Evaluation 
Advisory Committee

AGENCY: Office of National Drug Control Policy.

[[Page 57100]]


ACTION: Notice of meeting.

-----------------------------------------------------------------------

SUMMARY: The Drug Control Research, Data, and Evaluation Advisory 
Committee will meet to conduct ordinary business including discussions 
concerning the long-term and short-term planning for potential research 
projects.

DATES: The meeting will be held Wednesday, October 27, 2004 from 10 
a.m. to 5 p.m. and Thursday, October 28, 2004 from 9 a.m. to 5 p.m. 
There will be an opportunity for public comment from 4:30 p.m. to 5 
p.m. on Wednesday, October 27, 2004.

ADDRESSES: The meeting will be held at the Office of National Drug 
Control Policy, 750 17th Street, NW., 5th Floor Conference Room, 
Washington, DC.

FOR FURTHER INFORMATION CONTACT: Janie Dargan, (202) 395-6714.

    Dated: September 17, 2004.
Daniel R. Petersen,
Assistant General Counsel.
[FR Doc. 04-21327 Filed 9-22-04; 8:45 am]
BILLING CODE 3180-02-P
IN THE MATTER OF THE * IN THE

APPLICATION TO RESIGN FROM 

FROM THE PRACTICE OF LAW * COURT OF APPEALS

OF JONATHAN DAVID SUSS 

 * OF MARYLAND

 * Misc. Docket AG No. 90

 

* September Term, 2020

 

O R D E R

Upon consideration of the Application to Resign from the Practice of Law of 

Jonathan David Suss and the response of Bar Counsel, filed in the above-captioned case, 

it is this 15th day of June, 2021

ORDERED, by the Court of Appeals of Maryland, that the resignation of 

Jonathan David Suss from the Bar of the State of Maryland is hereby accepted; and it is 

further

ORDERED, that the Clerk of this Court shall remove the name Jonathan David 

Suss from the register of attorneys in the Court and certify that fact to the Trustees of the 

Client Protection Fund of the Bar of Maryland and the Clerks of all judicial tribunals in 

this State.

 

 /s/ Mary Ellen Barbera

 Chief Judge
Final Listing of Questionnaire Files for Steam Electric Rulemaking Record

Plant ID 04388

Removed 

from Public 

(Non-CBI) 

Docket1

Copyright 

Flag2

File Name Description

04388\04388_HardcopyLog.doc EPA log of hardcopy documents submitted

x 04388\04388_Part A.xls Plant submitted survey file

x 04388\04388_Part B.xls Plant submitted survey file

x 04388\04388_Part C.xls Plant submitted survey file

x 04388\04388_Part D.xls Plant submitted survey file

x 04388\04388_Part H.xls Plant submitted survey file

04388\Certification Statement Plant ID 04388.pdf Plant certification statement

04388\Supplemental Documents\04388_Aerial Map.pdf Plant submitted supplemental files to the survey

x 04388\Supplemental Documents\04388_D-1.pdf Plant submitted supplemental files to the survey

x 04388\Supplemental Documents\04388_WB-1.pdf Plant submitted supplemental files to the survey

x 04388\04388_Checklist.xls EPA Technical Review Checklist Workbook

04388\04388_Completeness_Checklist.xls EPA Completeness Review Checklist

1

 Final reviewed survey responses are located in the Steam Electric Technical Questionnaire Database . 

2

 Copyright documents are available from the docket.
Exhibit
10.18


 


First
Amendment to Employment Agreement


 


WHEREAS,
MYMD Pharmaceuticals. Inc (the “Company”) and Paul M. Rivard, Esq. (“Employee”) (collectively “the Parties”)
entered into an Employment Agreement dated September 21, 2020 (“Agreement”); and


 


WHEREAS,
for good and valuable consideration the Parties hereby wish to amend the Agreement as follows:


 


Exhibit
“C” to the Agreement is replaced with the Exhibit “C” appended hereto.


 


	 	MYMD
Pharmaceuticals, Inc.
	 	 
	 	/s/
James A. McNulty 
	 	By:
    James A. McNulty, CEO
	 	 
	 	Paul
    M. Rivard, Esq.
	 	 
	 	/s/
    Paul M. Rivard, Esq.


 




    	1



     


    

 


EXHIBIT
“C”


 


Milestone
Bonuses due upon achievement of milestones


 


Set
forth below is the schedule pursuant to which the Employee will be paid $20,000 at the time each of the pending patent applications are
issued to the Company. Each bonus will be paid 30 days after receipt of the Issued Patent.


 


	Title	 	Assignee	 	App.
    No. 	 	Estimated
    (Actual) Issuance
	Methods
    of Reversing Normal Aging Process and Extending Lifespan	 	MyMD
    Pharmaceuticals, Inc.	 	16/680,677	 	2Q
    2021
	 	 	 	 	 	 	 
	Pharmaceutical
    Salts of Isomyosmine and Pharmaceutical Compositions Containing Same	 	MyMD
    Pharmaceuticals, Inc.	 	16/672,714	 	(10/20/2020)
	 	 	 	 	 	 	 
	Method
    of Regulating Tumor Necrosis Factor-alpha (TNF-α) for Treating Cancers, Autoimmune Disorders, and Other Disorders Associated
    with Chronic Inflammation	 	MyMD
    Pharmaceuticals, Inc.	 	16/785,747	 	(11/17/2020)
	 	 	 	 	 	 	 
	Method
    of Treating Viral Infections	 	MyMD
    Pharmaceuticals, Inc.	 	16/791,290	 	(9/29/2020)
	 	 	 	 	 	 	 
	Method
    of Treating Coronavirus	 	MyMD
    Pharmaceuticals, Inc.	 	16/792,492	 	1Q
    2021
	 	 	 	 	 	 	 
	Methods
    of Regulating Oxidoreductase for Treatment of Aging and Age-related Disorders	 	MyMD
    Pharmaceuticals, Inc.	 	16/928,255	 	4Q
    2021
	 	 	 	 	 	 	 
	Method
    of Treating Disorders Associated with Chronic Inflammation	 	MyMD
    Pharmaceuticals, Inc.	 	17/084,012	 	1Q
    2022
	 	 	 	 	 	 	 
	Synthetic
    Cannabinoid Compounds for Treatment of Substance Addiction and Other Disorders	 	Supera
    Pharmaceuticals, Inc.	 	16/612,472	 	1Q
    2021


 




    	2
- All
            - Title
            - Author
            - Subject
            - Date
            - Full-Text

            -                              Explore                            ******                - Educational Resources
              - Archival Collections
              -                                      Themes                                    ******                  - Economic Data
                - Federal Reserve
                - View all 
              - Timelines 
            -                              Browse                            ******                - Titles
              - Authors
              - Subjects
              - Dates 
            -                              About                            ******                - About FRASER
              - FAQ
              - Contact Us
              -                                      FRASER API                                    ******                  - REST API
                - OAI-PMH 
            - Inside FRASER Blog

            - **

Home                 > Browse by Title > Pamphlets of the Women's Bureau

              																			United States. Women's Bureau.				"What Social Security Means to Women, Pamphlet 3,"		*Pamphlets of the Women's Bureau*		(1957).				https://fraser.stlouisfed.org/title/266/item/5915, accessed on September 22, 2024.	    

        - **FRASER**
        - About
        - FAQ
        - Legal and Privacy
        - FRASER API

          -                              @FedFRASER 
          - ** Contact Us
          -  **  What's New  
          -  **  Inside FRASER